Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,858

Document Document Title
WO/2018/071323A1
A method for assessing susceptibility to nausea of a patient comprises assessing the GSH recycling dependent antioxidant activity of the patient's blood cells prior to receiving an emetogenic agent, e.g., a cytostatic agent or a surgical...  
WO/2018/063010A1
The invention relates to a novel lupeol derivative, which is the ester of 4-picolinic acid (isonicotinic acid) and 20(29)-lupen-3.beta.-ol (lupeol), having structural Formula (1). The novel lupeol derivative is a result of modification o...  
WO/2018/059922A1
The present invention relates to a film-coated swallowable tablet comprising deferasirox in an amount of at least 60% by weight based on the total weight of the tablet and poloxamer, wherein the weight ratio of deferasirox to poloxamer i...  
WO/2018/053397A1
The invention relates to methods of treating or preventing organophosphate poisoning in a subject in need thereof, comprising administering to the subject isoflurane, enflurane, halothane, sevoflurane, desflurane, xenon or argon in a the...  
WO/2018/050938A1
The invention relates to a pre-loaded injectable device comprising or consisting of the composition according to the invention, the injectable pharmaceutical form, the combined preparation, or the pre-loaded injectable device for treatin...  
WO/2018/048812A1
Provided herein are pharmaceutical formularions comprising a 1,2-HOPO chelating agent and/or 3,2-HOPO chelating agent.  
WO/2018/035613A1
Disclosed are chelating co-polymer compositions that are soluble in aqueous media and chelate essential metals, methods of preparation and uses thereof. The chelating compositions are comprised of two or more different monomers, at least...  
WO/2018/039487A1
The invention provides compounds having the general formula I: and pharmaceutically acceptable salts thereof, wherein the variables R1, R2, R3, R4, subscipt m and n, have the meaning as described herein, and compositions containing such ...  
WO/2018/039526A1
Methods for managing pain, treating pain, and treating neurodegenerative disorders. The methods include administering to a subject in need thereof: (A) a therapeutically effective amount of simvastatin or a pharmaceutically acceptable sa...  
WO/2018/033249A1
The present invention provides a pharmaceutical preparation and in particular a combination of a pharmaceutical preparation and hyaluronic acid for use as a medicament, wherein the pharmaceutical preparation is injected into an intact sk...  
WO/2018/033226A1
The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an orga...  
WO/2018/033227A1
The present invention relates a pharmaceutical preparation for use in the treatment of ageing or as an anti-ageing agent, which is preparable by a production method comprising the following steps: providing a liquid collected from an org...  
WO/2018/023857A1
Provided are a Ganoderma polysaccharide, combination thereof, and manufacturing method of same. The Ganoderma polysaccharide is a Ganoderma lingzhi polysaccharide with a potassium ligand. The polysaccharide provides the following benefit...  
WO/2018/024887A1
The invention relates to a composition for use in the therapy of veisalgia. The composition comprises at least one sugar compound, mineral salts, at least one compound for cell protection, at least one compound for promoting cell functio...  
WO/2018/018783A1
A method for manufacturing a probiotics finishing agent, comprising the following steps: culturing probiotics; microencapsulating the probiotics; enabling the probiotics to be dormant; and blending an adhesive of microcapsules. The metho...  
WO/2018/021447A1
The purpose of the present invention is to provide a novel compound having D3 receptor antagonistic effect. Provided are the following: a compound represented by formula (I) (in the formula, ring A is a heterocyclic ring, X1 groups are e...  
WO/2018/016393A1
The present invention addresses the problem of providing a composition for preserving deoxyribonucleic acid which secures a sufficient supply amount and contributes to production cost reduction. The composition according to the present i...  
WO/2018/016523A1
Provided is a novel radioprotectant that comprises a compound represented by formula (I) or a pharmaceutically acceptable salt thereof as an active ingredient [in formula (I): a ring A represents a fused ring; and R1 represents a hydroge...  
WO/2018/015602A1
The present invention discloses the amino-terminal sequence of avian albumin bound to divalent cations such as copper or zinc, and any recombinant or fusion protein comprising said sequence for use thereof as a medicinal product, specifi...  
WO/2018/014068A1
The present invention provides a combination therapy for treating a tumor in a subject. The combination therapy comprises administration of (i) an antibody which binds to a cell surface-associated antigen expressed on the tumor cell, and...  
WO/2018/014068A9
The present invention provides a combination therapy for treating a tumor in a subject. The combination therapy comprises administration of (i) an antibody which binds to a cell surface-associated antigen expressed on the tumor cell, and...  
WO/2018/014067A1
The present invention provides a combination therapy for treating a tumor in a subject. The combination comprises two elements. The first is a polypeptide construct comprising an attenuated Type 1 interferon (IFN) linked to an antibody w...  
WO/2018/010588A1
A therapeutic agent for restoring body function aging and delaying organ function decline, and particularly a therapeutic agent comprising mesenchymal stem cells, especially stromal cells having positive expression of GD2 and hematopoiet...  
WO/2018/014016A1
Substance P analogs are useful for treating and protecting against exposure to ionizing radiation such as acute radiation syndrome, chronic radiation syndrome and the like. The active agents can be administered via inhalation therapy, in...  
WO/2018/010332A1
The present invention belongs to the field of pharmaceutical chemical technologies, and in particular relates to the use of 7-hydroxy-butyphthalide in the preparation of drugs for preventing and/or treating cardiovascular and cerebrovasc...  
WO/2018/000047A1
The present invention relates to the use of substituted quinoline compounds for treating immunoglobulin light chain (LC) amyloidosis (AL), especially cardiotoxicity associated with immunoglobulin LC AL. In particular, the substituted qui...  
WO/2018/001273A1
Provided are a peptide or a salt thereof, and a preparation method therefor. The peptide may be selected from VVYP, AVLP, IGFP, LLIIVP and STAP. The preparation method comprises steps as follows: using a resin as a starting material, lin...  
WO/2017/218845A1
Oxidative stress is linked to several health conditions including, without limitation, cancer, aging, neurodegenerative and metabolic diseases. Increased levels of oxidative stress may result from increased exposure to radiation or other...  
WO/2017/211617A1
The present invention relates to a compound for use as a medicament in the treatment or prevention of acute liver failure, which acute liver failure is induced by intoxication prior to or following administration of the compound. Accordi...  
WO/2017/206026A1
Disclosed are a composition and use thereof, the composition comprising the following components in parts by weight: 1 to 500 parts o f astaxanthin; 1 to 1000 parts of a potassium salt; 1 to 500 parts of a calcium salt; 1 to 500 parts of...  
WO/2017/208172A1
The present invention relates to a composition for use as a medicament, in the form of a gel with characteristics of a reversible thermogel, based on one or more poloxamers, water and optionally excipients, and an effective amount of an ...  
WO/2017/206105A1
An edible composition comprising an insoluble fiber and a prebiotic and liquid-absorbable gel can reduce the digestion or absorption of the harmful/toxic substance existed in food or drink.  
WO/2017/209934A1
An autophagy activator, such as vitamin D, for use in a method of treating or preventing skin damage in a subject in need thereof is described, that includes administering to the subject a therapeutically effective amount of said activat...  
WO/2017/204619A1
The present invention provides an aqueous extract of Andrographis paniculata leaves containing as main components andrographolide, neoandrographolide and 14-deoxy-11,12-didehydroandrographolide. The Invention also provides a method of pr...  
WO/2017/197793A1
A life-prolonging liquor, consisting of the components of: 10 g of Herba Cistanche, 20 g of Radix Rehmanniae, 10 g of Radix Rehmanniae Preparata, 10 g of Radix Asparagi, 10 g of Radix Ophiopogonis, 20 g of Radix Angelicae Sinensis, 10 g ...  
WO/2017/199073A1
An oral pharmaceutical formulation for effervescent tablet of deferiprone is reported comprising of deferiprone and a taste-masking composition consisting of an effective amount of sweetener and flavoring agent and containing appropriate...  
WO/2017/197781A1
The present invention provides a health-care and body-strengthening Fructus Lycii liquor, comprising the following components: Fructus Lycii: 50 g; Flos Chrysanthemi: 50 g; Radix Rehmanniae Preparata: 45 g; stir-baked Massa Medicata Ferm...  
WO/2017/195359A1
This hop processed product for suppressing fat accumulation or for antioxidation contains greater than or equal to 50 wt%, preferably greater than or equal to 60 wt%, and most preferably greater than or equal to 70%, of hop flowers (E・...  
WO/2017/193458A1
Disclosed are an organosilicone modified acrylic polyester potassium salt and a preparation method therefor. The organosilicone modified acrylic polyester potassium salt is prepared from an acrylic acid or esters thereof, acrylic organos...  
WO/2017/192581A1
Provided herein are methods for treating a subject in need of such treatment comprising administering a therapeutically effective amount of one or more pharmaceutical compositions comprising a 1,2-HOPO chelating agent and/or a 3,2-HOPO c...  
WO/2017/185280A1
Disclosed are a biological compound preparation which can improve altitude hypoxia tolerance and a preparation method thereof, comprising the raw materials by weight: 2-10 parts of folium ginkgo extract, 5-15 parts of guarana extract, 10...  
WO/2017/180591A1
The invention provides nanozymes that accumulate in the kidney and methods for their use.  
WO/2017/174744A1
A delivery system comprising hydrogen peroxide or a hydrogen peroxide generator system, for use in a method for the treatment or prevention of inflammatory bowel disease in a mammal, is described. The method comprises a step of orally ad...  
WO/2017/170762A1
The purpose of the present invention is to provide a tablet having sufficient strength and containing spherical adsorptive carbon for oral administration. This purpose is met with a tablet that contains spherical adsorptive carbon for or...  
WO/2017/170764A1
The purpose of the present invention is to provide a tablet, and a production method thereof, which has a high absorption rate of spherical adsorptive carbon for oral administration, and a high uniformity of the spherical adsorptive carb...  
WO/2017/169652A1
The method for producing polyphenols according to one embodiment of the present invention comprises a step for mixing used tea leaves with water to generate a liquid mixture. The liquid mixture is heated. From the heated liquid mixture, ...  
WO/2017/160864A1
The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesi...  
WO/2017/160864A8
The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesi...  
WO/2017/158041A1
The present invention relates to compositions comprising at least one film- forming agent able to adhere in a stable way to the mucosa of the mouth, esophagus and upper airways, establishing a mechanical form of protection against attack...  
WO/2017/159554A1
The invention provides a crystal of glutathione having excellent flowability and pulverizability, and a method for producing the same. The invention relates to a crystal of reduced-form glutathione, wherein the average crystal thickness ...  

Matches 1 - 50 out of 11,858